Anti‑Obesity Drugs Market to Reach USD 100.97 Billion by 2030, Driven by GLP‑1 Incretins and Uptake of Oral Treatments
Mordor Intelligence has published a new report on the Anti‑Obesity Drugs Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Introduction
Mordor Intelligence, in its latest anti‑obesity drugs market report, forecasts the market to reach from USD 25.93 billion in 2025 to USD 100.97 billion by 2030, advancing at a 31.24 % CAGR. The anti-obesity drugs market focuses on medications developed to aid in weight loss and manage obesity related conditions. Obesity is a chronic, relapsing condition associated with several health issues, including type 2 diabetes, cardiovascular diseases, sleep apnea, and certain cancers. As global obesity rates rise driven by sedentary lifestyles, poor dietary habits, and genetic factors, there is growing demand for medical interventions beyond lifestyle changes and bariatric surgery.
Key Trends
The anti‑obesity drugs landscape is being reshaped by several important developments:
1. GLP‑1 receptor agonists gaining dominance Gut‑hormone incretins, primarily GLP‑1 agonists, are set to expand at 33.15 % CAGR through 2030. Their strong efficacy in reducing weight and favorable safety profiles have led major pharmaceutical companies to scale up production and secure lifecycle extensions for these agents
2. Oral formulations on the rise Although injectables account for 81.3 % of the 2024 market share, oral anti‑obesity drugs are projected to grow at an impressive 36.6 % CAGR through 2030. This surge reflects patient preference for pill-based therapies and investment in oral GLP‑1 pills by developers.
3. Prescription segment maintains leadership Prescription drugs commanded 84.2 % of the anti‑obesity drugs market in 2024. Over‑the‑counter options trail behind but are gaining traction, with the prescription category still growing at a 32.56 % CAGR through 2030
4. Digital pharmacies unlocking access Retail pharmacies held 54.05 % of the market in 2024, but online pharmacies are catching up. They are expected to grow at a 34.75 % CAGR, spurred by e‑commerce ease and expanding reimbursement support.
5. Asia‑Pacific emerging fast North America remains the largest market with a 65.9 % revenue share in 2024. However, Asia‑Pacific is advancing at a robust 33.65 % CAGR, driven by rising healthcare spending and expanding obesity awareness.
Market Segmentation
The anti‑obesity drugs market can be segmented in multiple ways, enabling stakeholders to identify growth pockets and tailor strategies.
By Mechanism of Action
Peripherally acting drugs led revenue in 2024, capturing 60.10% of the market. These medications act within the digestive system, such as fat‑absorption inhibitors and appetite suppressants, reducing energy uptake or signalling fullness.
Gut‑hormone incretins (e.g., GLP‑1 agonists) are the fastest growing segment, forecast to expand at a 33.15% CAGR through 2030. These therapies mimic or enhance gut hormones to regulate appetite and blood sugar.
Prescription drugs held a dominant share at 84.20% in 2024. This category includes clinically validated medications with regulatory backing and reimbursement frameworks.
Over‑the‑counter (OTC) drugs occupy a smaller share but are gradually gaining influence through ease of access and increasing consumer trust.
By Route of Administration
Injectables commanded 81.30% of the market in 2024, driven by the widespread use of injectable GLP‑1 therapies known for their strong efficacy.
Oral drugs are emerging as the most dynamic segment, projected to grow at a 36.60% CAGR from 2025 to 2030, reflecting a clear patient trend toward pills over injections.
By Distribution Channel
Retail pharmacies made up 54.05% of market revenues in 2024, remaining the standard way for patients to obtain anti‑obesity medications.
Online pharmacies are fast growing (projected 34.75% CAGR to 2030), propelled by telehealth, convenient home delivery, and evolving reimbursement policies.
By Geography
North America was the largest regional market, securing a 65.90% share in 2024. This dominance stems from advanced healthcare systems, approval frameworks, and strong payer support.
Asia‑Pacific is the fastest expanding region, with a projected CAGR of 33.65%. Growth drivers include rising obesity awareness, healthcare investments, and broader pharmaceutical access.
Key Players
Roche
Roche is a global pharmaceutical company that has recently entered the anti-obesity drugs market. The company has secured licensing agreements for potential weight loss candidates, signaling its interest in expanding its portfolio to include obesity treatments. Roche's expertise in biotechnology and commitment to addressing unmet medical needs position it as a noteworthy participant in the obesity care landscape.
GlaxoSmithKline (GSK)
GSK is a multinational healthcare company involved in the development of various therapeutic areas, including obesity. The company is exploring the potential of amylin analogs and other hormonal agents for weight management. GSK's research initiatives aim to provide patients with alternative treatment options and contribute to the advancement of obesity care.
Novo Nordisk
Novo Nordisk is a leading global healthcare company specializing in diabetes and obesity care. The company has developed several GLP-1 receptor agonists, including semaglutide (marketed as Ozempic and Wegovy), which have shown significant efficacy in weight management. Novo Nordisk continues to invest in research and development to expand its portfolio of anti-obesity medications and enhance patient outcomes.
Currax Pharmaceuticals
Currax Pharmaceuticals is a biopharmaceutical company specializing in the development and commercialization of treatments for obesity. Through strategic acquisitions, such as obtaining rights to Contrave, Currax has expanded its presence in the anti-obesity drugs market. The company's focus on addressing obesity-related health issues aligns with the growing demand for effective weight management therapies.
Eli Lilly and Company
Eli Lilly is another major player in the anti-obesity drugs market, known for its innovative therapies. The company's GLP-1 receptor agonist, tirzepatide (marketed as Mounjaro), has demonstrated promising results in clinical trials for weight loss. Eli Lilly's commitment to obesity care is reflected in its ongoing research efforts and strategic partnerships aimed at advancing treatment options for patients.
Conclusion
The anti‑obesity drugs market is entering a transformative era, with expected growth from USD 25.93 billion in 2025 to USD 100.97 billion by 2030 at a 31.24 % CAGR. This growth is fuelled by the powerful clinical outcomes of GLP‑1 agonists, innovation in oral formulations, expanded access via online pharmacies, and increasing attention to obesity as a chronic disease.
While North America remains the dominant market, Asia‑Pacific's rapidly growing demand offers substantial opportunities. Competition is intensifying, as established pharmaceutical companies and biotechs alike race to advance next generation therapies and diversify distribution channels.
As market dynamics evolve, stakeholders should monitor:
• Progress of oral GLP‑1 candidates and dual/triple‑agonists like CagriSema
• Regulatory approvals and reimbursement pathways, especially in emerging regions
• Competitive responses from lifecycle extensions to partnerships and acquisitions
• Supply chain robustness and accessibility, particularly amid supply constraints for high‑demand drugs
In sum, the anti‑obesity drugs market is poised for significant expansion, with transformative treatments and shifting delivery models likely to reshape global healthcare delivery and patient outcomes.
Industry Related Reports
Ozempic Market : The Ozempic Market Report is segmented by region, including North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America. The report provides both value (in USD) and volume (in units) for each of these segments.
Japan Oral Anti-Diabetic Drug Market: The Japan Oral Anti-Diabetic Drug Market Report is segmented by drug types, including Biguanides, Alpha-Glucosidase Inhibitors, GLP-1 Receptor Agonists, SGLT-2 Inhibitors, DPP-4 Inhibitors, and others, as well as end users, such as Hospitals/Clinics, Personal/Home Care Settings, and others. The report provides market size and forecasts for each segment in terms of value (USD).
Get More Insights:
Anti-Snoring Market: The Anti-Snoring Devices Market report segments the industry by device type, including Mandibular Advancement Devices (MAD), Tongue Stabilizing Devices (TSD), Continuous Positive Airway Pressure (CPAP) Devices, and other device types. It also segments by surgical procedures such as Uvulopalatopharyngoplasty (UPPP), Somnoplasty, Pillar Procedure, Tonsillectomy, Radiofrequency Palatoplasty, and more. Additionally, the report covers geographical segmentation.
About Mordor Intelligence: Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact: media@mordorintelligence.com https://www.mordorintelligence.com/
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
29 minutes ago
- Globe and Mail
As Musk's 'robotaxi' rollout approaches, Democratic lawmakers in Texas try to throw up a roadblock
NEW YORK (AP) — A group of Democratic lawmakers in Texas is asking Elon Musk to delay the planned rollout of driverless 'robotaxis' in the state this weekend to assure that the vehicles are safe. In a letter, seven state legislators asked Tesla to wait until September when a new law takes effect that will require several checks before autonomous vehicles can be deployed without a human in the driver's seat. Tesla is slated to begin testing a dozen of what it calls robotaxis for paying customers on Sunday in a limited area of Austin, Texas. 'We are formally requesting that Tesla delay autonomous robotaxi operations until the new law takes effect on September 1, 2025,' the letter from Wednesday, June 18, reads. 'We believe this is in the best interest of both public safety and building public trust in Tesla's operations.' It's not clear if the letter will have much impact. Republicans have been a dominant majority in the Texas Legislature for more than 20 years. State lawmakers and Republican Gov. Greg Abbott have generally embraced Musk and the jobs and investment he has brought to Texas, from his SpaceX rocket program on the coast, to his Tesla factory in Austin. The company, which is headquartered in Austin, did not responded immediately to a request for comment from The Associated Press. The law will require companies to secure approval from the state motor vehicles department to operate autonomous cars with passengers. That approval, in turn, would depend on sufficient proof that the cars won't pose a high risk to others if the self-driving system breaks down, among other reassurances. Companies would also have to file detailed plans for how first responders should handle the cars if there is a problem, such as an accident. The letter asked Tesla to assure the legislators it has met all the requirements of the law even if it decides to go ahead with the test run this weekend. The letter was earlier reported by Reuters. Musk has made the robotaxi program a priority at Tesla and a failure would likely be highly damaging to the company's stock, which has already tumbled 20% this year. Musk's political views and his affiliation with the Trump administration have drastically reduced sales of Tesla, particularly in Europe, where Musk's endorsement of Germany's far-right Alternative for Germany party in February's election drew broad condemnation. Tesla shares bottomed out in March and have rebounded somewhat in recent months. Much of the rise reflects optimism that robotaxis will not only be deployed without a hitch, but that the service will quickly expand to other cities and eventually dominate the self-driving cab business. Rival Waymo is already picking up passengers in Austin and several other cities, and recently boasted of surpassing 10 million paid rides. In afternoon trading Friday, Tesla shares were largely unchanged at $320.
Globe and Mail
44 minutes ago
- Globe and Mail
Golden ADU Transforms Retired Teacher's Property Into a Rental Unit, With No Upfront Costs
When Cynthia R., a 67-year-old retired teacher from Lake View Terrace, first considered building an Accessory Dwelling Unit (ADU) on her property, she was uncertain about its feasibility. Living on a quiet residential street in a modest single-story home with a detached garage and sizable backyard, her vision was to create a small rental unit: either for her adult son or to supplement her retirement income. However, the process initially felt daunting. Cynthia reached out to several companies, only to encounter vague responses or aggressive sales pitches before anyone evaluated whether her property was suitable for development. That changed when she connected with Golden ADU, a Los Angeles-based company specializing in ADU development. Golden ADU's team provided a free, no-pressure onsite assessment. They measured her property's setbacks, evaluated the slope, and reviewed local zoning regulations. The results confirmed her eligibility to build an ADU, and the company offered a groundbreaking proposal: Cynthia wouldn't need to pay anything upfront. The cost could be deferred until after the project was completed. 'That was a game changer,' Cynthia said. 'I didn't have to empty my savings or take out a risky loan.' Six months later, Cynthia's detached garage had been professionally converted into a fully permitted one-bedroom ADU, complete with its own kitchen, bathroom, and private entrance. Her son moved in and began paying a modest rent, less than the local market rate, but enough to provide consistent monthly support. Golden ADU's commitment to accessibility, transparency, and tailored service helped Cynthia achieve a long-standing dream without financial strain. 'They didn't just build me a unit,' she noted. 'They gave me peace of mind, independence, and a future.' Golden ADU continues to serve homeowners across Los Angeles by offering city-approved ADU solutions with a streamlined process, from free onsite evaluations to the final completion. Their mission is to make ADUs achievable for homeowners looking to generate income, accommodate family members, or increase long-term property value. For more information, please visit: Find us at Follow Golden ADU on Social Media. Instagram: YouTube: Media Contact Company Name: Golden ADU Contact Person: Jordan Shm Email: Send Email City: Los Angeles State: California Country: United States Website:
Globe and Mail
44 minutes ago
- Globe and Mail
Payroll Outsourcing Services by IBN Technologies Help New York Firms Thrive Amid Market Shifts
New York businesses are turning to Payroll Outsourcing Services from IBN Technologies to manage rising labor costs, evolving tax laws, and complex compliance challenges. Serving industries like healthcare, retail, and IT, IBN delivers full-cycle payroll, tax filing, and multi-state processing through secure, integrated systems. These services reduce risk, boost accuracy, and support business growth across the state. Miami, Florida - 20 June, 2025 - Businesses throughout New York are turning to outside experts rather than internal payroll departments due to growing labor expenses, changing staff compositions, and a more complicated regulatory environment. Payroll issues include seasonal workforce unpredictability, union compliance, and multi-state employee registrations for businesses in a variety of industries, from healthcare and construction to retail and IT. As a result, more businesses are using payroll outsourcing services to effectively satisfy regulatory standards, improve payroll processes, and lower mistakes. Businesses may boost employee happiness, guarantee prompt salary distribution, and manage operations more affordably with the help of these outsourced solutions. Payroll outsourcing is increasingly required rather than optional, which highlights a broader shift in the corporate environment. In response to the increasing need for payroll systems that are expert-driven, scalable, and compliant, companies like IBN Technologies are offering sector-specific solutions that improve accuracy and lessen internal stress. By using hr and payroll outsourcing solutions, businesses may reduce their administrative burden and refocus their attention on expanding their operations. Payroll operations are being repositioned as a strategic function that generates company value with the help of a reliable partner like IBN Technologies. Simplify payroll with expert-led, compliant solutions today Request a Free Consultation Now: Payroll Complexity and Compliance Challenges Organizations in New York and the rest of the United States are facing more complicated payroll management challenges because of changing regulations and growing operational needs. The administrative burden is growing, ranging from tax filings and multi-jurisdictional reporting to wage computation and benefit allocations. Inaccuracies in these areas frequently lead to fines from the government, unhappy workers, or damage to one's image. Key compliance challenges include: Navigating frequent changes in payroll regulations at state and federal levels Complex calculations involving taxes, bonuses, and benefit deductions Risk of delayed filings and submission penalties Secure distribution of pay across various employee classifications Burdensome documentation and audit trails Maintaining compliance across states and localities with differing requirements To mitigate these risks and optimize efficiency, businesses are increasingly choosing to outsource payroll service operations. These providers handle every aspect of payroll—processing, tax filings, reporting, and compliance monitoring—resulting in improved accuracy, reduced internal pressure, and streamlined payroll cycles across diverse locations. IBN Technologies: Expert Payroll Outsourcing Services for Modern Businesses IBN Technologies provides a comprehensive range of payroll outsourcing services designed to meet the unique requirements of companies in New York. Their strong payroll system is designed to guarantee accuracy, satisfy legal requirements, and develop alongside businesses in a variety of sectors. • Complete Payroll Management – From gross-to-net processing to direct deposits, every step is handled with precision and regulatory adherence. • Accurate Tax Filing – Calculations, deductions, and filings at federal, state, and local levels are completed with meticulous attention. • Regulatory Reporting – Including year-end forms such as W-2s and 1099s, supporting compliance documentation, and on-demand reports. • Multi-State Capabilities – Payroll management for businesses operating across various state jurisdictions with differing employment laws. • Employee Access – Secure portals providing access to payslips, tax forms, and balances for transparency and convenience. IBN Technologies enhances its offerings through state-of-the-art payroll software for payroll service providers, ensuring seamless automation, secure processing, and end-to-end payroll visibility. By integrating accounting platforms such as QuickBooks, Xero, and NetSuite, the service delivers real-time synchronization and error-free financial reporting. Leveraging encryption, customizable dashboards, and automatic tax updates, IBN Technologies combines reliability with data security, supporting a dynamic and scalable payroll environment. Strategic Advantages for Business Operations With its deep industry knowledge and hands-on approach, IBN Technologies delivers payroll solutions that reduce liability and ensure business continuity. Their technology-backed services, supported by expert professionals, provide numerous operational benefits: • Guaranteed 100% accuracy in payroll with customized small business payroll processing to avoid financial discrepancies • Direct access to experienced payroll professionals for immediate issue resolution • Support for year-end filing and reporting obligations including W2s and 1099s • Assurance of full labor law and tax code compliance • Timely salary disbursement to maintain employee satisfaction and trust IBN Technologies' solutions are crafted to support businesses as they navigate increasing regulatory scrutiny and operational expansion. With customized strategies and secure delivery models, the company ensures payroll remains an enabler of business goals. Proven Impact and Industry Trust Errors and delays in the payroll processing process might impede expansion. In response, corporations in New York are collaborating with reputable companies that provide proactive assistance, quick installation, and trustworthy service. The advantages of selecting a seasoned small business payroll service provider like IBN Technologies become clear when the need for dependable, effective, and secure payroll procedures increases. Performance metrics from client engagements include: 95% of businesses report fewer payroll-related compliance issues after outsourcing An average of 20% cost savings realized through optimized payroll processes Professional account managers are assigned by a specialist payroll company such as IBN Technologies to guarantee regulatory compliance and timetable adherence. Their staff guarantees smooth service delivery in line with business objectives, whether they are handling startup-scale operations or enterprise-level payroll obligations. The Future of Payroll Management in New York According to industry observers, integrated strategic alliances are the key to payroll's future evolution. Outsourcing companies are evolving from basic suppliers to strategic business facilitators as employee expectations increase, and regulatory frameworks become more stringent. Offering flexible models, compliance automation, and direct customer interaction, IBN Technologies is one of the pioneers in this shift. Businesses prefer to have adaptable partners with demonstrated scalability and security as the need for digital-first payroll solutions increases. IBN Technologies gives clients the ability to handle payroll with the least amount of risk and the greatest amount of trust by providing constant accuracy and cross-functional knowledge. This contemporary approach to payroll outsourcing services is being adopted by companies looking to improve employee experience, save expenses, and harmonize operations. In today's business environment, precision, agility, and compliance are essential. IBN Technologies' commitment to excellence and innovation has earned the trust of companies across New York, offering them a smarter, safer, and more reliable path forward in payroll management. Related Service: Bookkeeping Services: About IBN Technologies IBN Technologies LLC, an outsourcing specialist with 25 years of experience, serves clients across the United States, United Kingdom, Middle East, and India. Renowned for its expertise in RPA, Intelligent process automation includes AP Automation services like P2P, Q2C, and Record-to-Report. IBN Technologies provides solutions compliant with ISO 9001:2015, 27001:2022, CMMI-5, and GDPR standards. The company has established itself as a leading provider of IT, KPO, and BPO outsourcing services in finance and accounting, including CPAs, hedge funds, alternative investments, banking, travel, human resources, and retail industries. It offers customized solutions that drive AR efficiency and growth. Media Contact Company Name: IBN Technologies LLC Contact Person: Pradip Email: Send Email Phone: +1 844-644-8440 Address: 66, West Flagler Street Suite 900 City: Miami State: Florida 33130 Country: United States Website:
